Bertram Timothy 4
4 · NexImmune, Inc. · Filed Feb 19, 2021
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Bertram Timothy
Director
Transactions
- Conversion
Common Stock
2021-02-17+44,965→ 51,415 total - Conversion
Common Stock
2021-02-17+10,344→ 61,759 total - Conversion
Common Stock
2021-02-17+16,440→ 78,199 total - Conversion
Series A Preferred Stock
2021-02-17−44,965→ 0 total→ Common Stock (44,965 underlying) - Conversion
Series A2 Preferred Stock
2021-02-17−10,344→ 0 total→ Common Stock (10,344 underlying) - Conversion
Series A3 Stock
2021-02-17−16,440→ 0 total→ Common Stock (16,440 underlying)
Footnotes (3)
- [F1]The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis.
- [F2]The shares of preferred stock were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering.
- [F3]Not applicable.